TheChek News Flow

>>> Up

* Ceconomy Raised to Neutral at Oddo BHF; PT 2.60 euros

* H+H Raised to Buy at Nordea; PT 120 kroner

* Norbit Raised to Buy at SpareBank; PT 75 kroner

* Storskogen Raised to Outperform at BNPP Exane (+)

* Stroeer Raised to Outperform at Oddo BHF; PT 100 euros
* Travis Perkins Raised to Overweight at Barclays; PT 1,050 pence

>>> Down

* ABN Amro GDRs Cut to Underperform at BNPP Exane (+)

* Alkemy Cut to Neutral at Mediobanca SpA; PT 11 euros

* Avance Gas Cut to Hold at Pareto Securities; PT 195 kroner

* Bergman & Beving Cut to Hold at DNB Markets; PT 250 kronor (+)

* ICE Fish Farm Cut to Hold at DNB Markets; PT 30 kroner

* IPC Cut to Hold at Jefferies; PT 140 kronor

* JCDecaux Cut to Neutral at Oddo BHF; PT 23 euros

* Knorr-Bremse Cut to Hold at Bankhaus Metzler; PT 77 euros (+)

* Leroy Cut to Hold at DNB Markets; PT 55 kroner (+)

* Marimekko Cut to Reduce at Inderes; PT 13 euros

* Neste Cut to Hold at SEB Equities; PT 21 euros

* Neste Cut to Accumulate at Inderes; PT 21.50 euros

* Orthex Cut to Hold at Nordea
* Porsche AG Cut to Reduce at AlphaValue/Baader

* Salzgitter Cut to Hold at Bankhaus Metzler; PT 23.50 euros (+)

* Thyssenkrupp Nucera Cut to Neutral at Grupo Santander

* Verbund Cut to Sell at Citi; PT 62 euros

* Volue Cut to Hold at Arctic Securities; PT 34 kroner

>>> Initiation
* DKSH Rated New Outperform at Oddo BHF; PT 76 Swiss francs

* Domino's Pizza Group Rated New Sell at Redburn; PT 300 pence

* Ebusco Holding Rated New Buy at Bryan Garnier; PT 5.50 euros (+)

* eDreams ODIGEO Rated New Buy at Bestinver; PT 8.30 euros (+)

* Greencoat UK Wind Rated New Outperform at Peel Hunt (+)

* Greggs Rated New Buy at Redburn; PT 3,280 pence

* Ipsos Rated New Buy at Berenberg; PT 89 euros

* Scandinavian Enviro Systems Rated New Buy at Pareto Securities

* Sectra Rated New Hold at SEB Equities; PT 245 kronor

* TFF Group Rated New Buy at Portzamparc; PT 57 euros (+)

>>> Call

* Morgan Stanley Data Show Novo Is Most Well-Owned European Stock (+)

* Roche Obesity Drug’s Potential Is Hard to Predict, Vontobel Says (+)
* Swiss Re 1Q Results Are Highly Reassuring, Jefferies Says (+)